GP-Leds

While impact secondaries transactions remain a relatively small part of overall secondaries volume, these vehicles can offer more certainty around impact-linked growth stories compared with their blind-pool counterparts.

Iron Road Partners’ Igor Rozenblit – former co-head of the SEC's private funds unit – details concerns and red flags the regulator will be looking for following the passing of its private market rules last year.

In episode five of the Decade of Secondaries Investing podcast miniseries, Iron Road Partners’ Igor Rozenblit and Ropes & Gray’s Isabel Dische discuss the regulatory landscape facing secondaries and analyse which rules are set to have the biggest impact.

The European buyout firm is seeking more time and capital to further grow Normec internationally while crystallising returns for investors.

Lawyers from Skadden, Arps examine how sale and purchase agreements have evolved to better fit sponsor-initiated processes.

The transaction involves five assets coming from three vehicles managed by the Jordan Company, Secondaries Investor understands.

In this third episode of the Decade of Secondaries Investing miniseries, Goldman's Harold Hope and Lazard's Holcombe Green discuss how continuation fund technology has developed to facilitate single-asset continuation funds and the runway for further growth.

Manulife Investment Management’s GP-led secondaries programme will seek out concentrated deals from the large-cap space through to the lower mid-market.

The transaction comes off the back of at least three other insurance-focused continuation fund deals in Europe over the past half-year.

The deal would allow Rubenstein to sell partial stakes in several assets, which will support his investment in the Baltimore Orioles Major League Baseball franchise, sources said.